Literature DB >> 18232594

Primary cerebral fibrosarcoma in a child.

G Torres1, F Petit, V Vilchez, Z Romero, S Dorfman, D Cardozo, J Cardozo.   

Abstract

OBJECTIVE: To describe the case of a primary cerebral fibrosarcoma in a child. CLINICAL CASE: A 6-year-old boy presented with a history of headache, drowsiness, vomiting and seizures. He was referred to our institution and died shortly upon arrival to the ER. The autopsy revealed a large left frontoparietal mass with histopathologic features characteristic of fibrosarcoma. Immunohistochemical and ultrastructural studies allowed the exclusion of other mimickers such as meningiomas, and neoplasms of glial or neuronal origin. No other growths were found in the CNS or in other parts of the body.
CONCLUSIONS: Brain fibrosarcoma is an exceedingly uncommon tumor. Only 41 cases have been reported to date. The diagnosis of fibrosarcoma must be based on the identification of a predominant herringbone architectural pattern, and immunohistochemical features, although the latter are of limited diagnostic value, its importance being that they facilitate the exclusion of other entities considered in the differential diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 18232594     DOI: 10.5414/npp26284

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  4 in total

1.  Primary intracranial fibrosarcoma presenting with hemorrhage.

Authors:  Jong Gon Lee; Sang Woo Song; Young-Cho Koh; Joon Cho; Jin Woo Choi; Hong Gee Roh; So-Dug Lim
Journal:  Brain Tumor Res Treat       Date:  2013-10-31

Review 2.  Epileptic seizure in primary intracranial sarcoma: a case report and literature review.

Authors:  Yen-Ping Chen; Hsiu-Fen Lee; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2016-07-12       Impact factor: 1.475

3.  Fibrosarcoma of the meninges.

Authors:  Ruchi Chopra; Minakshi Bhardwaj; Ishwar Chand Premsagar
Journal:  Rare Tumors       Date:  2010-03-31

4.  Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib.

Authors:  Daniela Alexandru; Denise K Van Horn; Daniela Annenelie Bota
Journal:  J Neurooncol       Date:  2009-12-31       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.